Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256839 · ClinicalTrials.gov registry record
Evaluation of the QuantiFERON-TB Test.
A clinical trial of Tuberculosis, sponsored by QIAGEN Gaithersburg.
- Completed
- Registry status
- 268
- Enrollment target
- 1
- Study location
NCT02256839 is a study of Tuberculosis that has completed, run by QIAGEN Gaithersburg. The registered enrollment target is 268 participants, below the 925-participant average among 29 other Tuberculosis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02256839, a study of Tuberculosis, has completed, sponsored by QIAGEN Gaithersburg.
- COMPLETED
- Registry status
- 268 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Conditions Studied
Interventions
- DEVICE CST_001
Study Locations (1)
Oregon
- Oregon Health & Sciences University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256839
The ClinicalTrials.gov registry entry for NCT02256839 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 925-participant average among 29 other Tuberculosis trials with a reported enrollment target (71% lower). The listed sponsor is QIAGEN Gaithersburg, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 1 intervention - of which CST_001 is the first listed.
NCT02256839 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT02256839 about?
NCT02256839 is a clinical study titled "Evaluation of the QuantiFERON-TB Test.". To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
What is the current status of trial NCT02256839?
This trial is currently completed. The enrollment target is 268 participants. The study started on 2014-10. Estimated completion is 2015-10.
What conditions does trial NCT02256839 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT02256839?
The interventions under investigation include: CST_001 (DEVICE).
Who is sponsoring clinical trial NCT02256839?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02256839 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.